ARKG ARK Genomic Revolution ETF
Company Analysis
Latest News
🟢 Health ETF (ARKG) is trading 6.9% up today on positive Moderna-Merck melanoma-vaccine results
ARKG is trading at $46.19 (+6.88%), driven by positive late-stage melanoma-vaccine results from Moderna and Merck lifting biotechnology and healthcare...
🟢 Health ETF (ARKG) is trading 4.1% up in pre-market after positive Moderna-Merck melanoma-vaccine results
ARKG is trading at $44.98, up +4.09% pre-market after positive late-stage melanoma-vaccine results from Moderna and Merck. - Combination therapy met key goals...
🟢 Health ETF (ARKG) is trading 3.2% up today on easier Fed policy expectations
ARKG is trading at $44.42 (+3.21%) as weaker July employment data boosts expectations for easier Federal Reserve policy. - Healthcare stocks are attracting...
🟢 Genomic Revolution ETF (ARKG) is trading 4.14% up today as biotech momentum strengthens
ARKG is trading 4.14% higher as biotechnology remains a strong market theme, supported by innovation, obesity-drug demand, and increased dealmaking. -...
🟢 ARKG is trading 3.1% up today on reports of a $400B AstraZeneca-Bristol Myers Squibb merger
ARKG is trading 3.1% up today as reports of a potential $400 billion mega-merger between AstraZeneca and Bristol Myers Squibb lift sentiment across the...
🟢 ARKG is trading 3.2% up today as biotech stocks rally amid easing macro tensions
ARKG is trading 3.2% up today as healthcare and biotech stocks rally alongside broader market gains in the S&P 500 and Nasdaq. • Easing Middle East tensions,...
🔴 ARKG is trading 3.1% down today as investors rotate away from high-risk biotech and genomics
ARKG is trading 3.1% down today as investors rotate away from higher-risk biotech and genomics names despite a generally mixed broader market. • The...
🟢 ARKG is trading 3.4% up today on cooler PCE data and biotech M&A optimism
ARKG is trading 3.4% up today as cooler PCE inflation data and strong technology earnings drive a broad risk-on rally, significantly improving market sentiment...
🔴 ARKG is trading 3% down today as biotech and genomics stocks weaken amid a broader Nasdaq selloff
ARKG is trading at $36.66 (-3.00%) as biotech and genomics names face pressure from a broader rotation out of high-growth healthcare. • The move aligns with a...
🟢 ARKG is trading 3.04% up today as healthcare and risk assets rally on easing macro fears
ARKG is trading at $38.96 (+3.04%) as healthcare and broader risk assets rally alongside major U.S. indices. • Lower oil prices and reduced Fed tightening...
🟢 ARKG is trading 3.1% up today on Eli Lilly’s $3.8B acquisition and biotech optimism
ARKG is trading at $39.45 (≈+3.1%) as Eli Lilly’s $3.8B acquisition of AtaiBeckley fuels momentum in the genomics and advanced therapeutics space. • Eli...
🔴 ARKG is trading 4.1% down today as investors reassess biotech valuations amid sector consolidation
ARKG is trading 4.1% down today as investors continue to reassess valuations in the innovative biotech and genomics sectors following a wave of M&A and sector...
🔴 ARKG is trading 3.3% down today as investors reassess valuations amid sector consolidation
ARKG is trading 3.3% lower today as investors reassess valuations in innovative healthcare following a surge in M&A activity and strategic deals. • The recent...
🔴 ARKG is trading 3% down today amid mixed healthcare earnings and macro jitters
ARKG is trading 3% down today as broader market weakness and macro uncertainty weigh on growth-focused healthcare exposures. • Risk-off sentiment is...
🔴 ARKG is trading 3.1% down today as healthcare policy concerns and broader geopolitical stress weigh on risk assets
ARKG is trading at $41.66 (-3.10%) amid sector-wide pressure from healthcare policy concerns and a broader risk-off market tone. • The healthcare sector is...